Diazepane Derivatives, Processes for their Preparation, and Uses thereof for the Amelioration, Prevention and/or Treatment of Mental and Neurological Diseases
US-2024246957-A1 · Jul 25, 2024 · US
US9371334B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9371334-B2 |
| Application number | US-201414496514-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 25, 2014 |
| Priority date | Sep 22, 2010 |
| Publication date | Jun 21, 2016 |
| Grant date | Jun 21, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Among other things, the present invention encompasses methods of synthesizing salicylaldehyde derivatives comprising the steps of: a) providing salicylaldehyde or a derivative thereof, b) forming an anhydro dimer of the provided salicylaldehyde compound, c) performing one or more chemical transformations on the anhydro dimer and d) hydrolyzing the anhydro dimer to provide a salicylaldehyde derivative different from that provided in step (a).
Opening claim text (preview).
What is claimed is: 1. A compound of any one of formulae D14 to D18: wherein, R 26 is selected from the group consisting of: hydrogen, halogen, optionally substituted C 1-20 aliphatic, and optionally substituted aryl; R a and R b are, independently at each occurrence, selected from the group consisting of hydrogen, halogen, and optionally substituted C 1-4 aliphatic; Q′ is selected from the group consisting of: halogen, hydroxyl, sulfonate ester, a neutral or cationic nitrogen-containing functional group, and a neutral or cationic phosphorous-containing functional group; and m is from 1 to 10. 2. The compound of claim 1 , wherein Q′ is selected from the group consisting of: bromine, chlorine, iodine, —OH, —OSO 2 R, —N(R) 2 , —N(R) 3 + , —P(R) 3 + , substituted guanidine, guanidinium, and amidine; wherein R is hydrogen; C 1 -C 20 alkyl; C 1 -C 20 alkyl having one or more functional moieties selected from the group consisting of halogen, nitrogen, oxygen, silicon, sulfur, and phosphorus; C 2 -C 20 alkenyl; C 2 -C 20 alkenyl having one or more functional moieties selected from the group consisting of halogen, nitrogen, oxygen, silicon, sulfur, and phosphorus; C 7 -C 20 alkylaryl; C 7 -C 20 alkylaryl having one or more functional moieties selected from the group consisting of halogen, nitrogen, oxygen, silicon, sulfur, and phosphorus; C 7 -C 20 arylalkyl; and C 7 -C 20 arylalkyl having one or more functional moieties selected from the group consisting of halogen, nitrogen, oxygen, silicon, sulfur, and phosphorus. 3. The compound of claim 2 , wherein Q′ is —OH. 4. The compound of claim 2 , wherein Q′ is bromine. 5. The compound of claim 1 , wherein Q′ is a guanidine. 6. The compound of claim 5 , wherein Q′ is 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD). 7. The compound of claim 2 , wherein Q′ is 7-methyl-1,5,7-triazabicyclo[4.4.0]dec-5-ene ([N-methyl TBD] + ). 8. The compound of claim 2 , wherein Q′ is trialkylammonium. 9. The compound of claim 1 , wherein R 26 is selected from the group consisting of: —H, halogen, methyl, ethyl, n-propyl, i-propyl, n-butyl, sec-butyl, and t-butyl. 10. The compound of claim 9 , wherein R 26 is t-butyl. 11. The compound of claim 1 , wherein m is an integer between 1 and 6. 12. The compound of claim 9 , wherein Q′ is TBD. 13. The compound of claim 9 , wherein Q′ is [N-methyl TBD] + .
Ortho-condensed systems · CPC title
Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00 · CPC title
Bridged systems · CPC title
Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 · CPC title
Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.